--- title: "Blog" url: https://virtue340b.com/content-hub/blog/ date: 2025-07-22 modified: 2026-07-24 lang: en author: "Toto SEO" description: "340B Insights 340B Growth in Context: What the Data Shows, and Why the Narrative Matters The 340B program has grown, but the narrative that this reflects misuse or drift from..." word_count: 601 --- # Blog # 340B Insights ## 340B Growth in Context: What the Data Shows, and Why the Narrative Matters The 340B program has grown, but the narrative that this reflects misuse or drift from its original intent is being built on an incomplete picture. When drug acquisition costs rise by more than 140% and patient complexity increases, spending follows. Before policy decisions are made, the data deserves an honest read. [Continue Reading →](https://virtue340b.com/340b-growth-in-context-what-the-data-shows/) [ ![](https://virtue340b.com/wp-content/uploads/2025/09/tablet-with-annual-report-1024x683.jpg) ](https://virtue340b.com/340b-growth-in-context-what-the-data-shows/) ## Jun 3 2026 ## Why Independent Oversight Matters in Vendor-Managed 340B Programs At GCA340B, staying ahead of the compliance curve isn't just a priority-it's the promise we make to every Covered Entity we serve. Compliance and auditing are at the heart of everything we do, and our partnership with Virtue340B further strengthens that foundation. Together, we create a unified front that helps our clients uncover vulnerabilities before… [Continue Reading →](https://virtue340b.com/why-independent-oversight-matters-in-vendor-managed-340b-programs/) [ ![340B Audits Graphs and Results](https://virtue340b.com/wp-content/uploads/2026/04/340b-audit-awards-partnerships-1024x729.jpg) ](https://virtue340b.com/why-independent-oversight-matters-in-vendor-managed-340b-programs/) ## Apr 7 2026 ## Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility A federal court ruling in Albany Med v HRSA is reshaping how 340B child site eligibility is evaluated. While registration may no longer define eligibility, organizations must now clearly document and defend how sites qualify under the program. [Continue Reading →](https://virtue340b.com/albany-med-vs-hrsa-the-decision-really-for-340b-child-site-eligibility/) [ ![340B Eligible Medications](https://virtue340b.com/wp-content/uploads/2026/03/340b-drug-admistration-virtue-1024x576.png) ](https://virtue340b.com/albany-med-vs-hrsa-the-decision-really-for-340b-child-site-eligibility/) ## Mar 27 2026 ## Virtue 340B partners with HANYS Marketplace Virtue 340B partners with HANYS Marketplace to support hospital leaders with independent 340B compliance insight and oversight clarity Virtue 340B® has partnered with HANYS Marketplace®, a for-profit subsidiary of the Healthcare Association of New York State, to support hospitals and health systems in strengthening program oversight and turning operational complexity into clear, executive-level insight. About HANYS… [Continue Reading →](https://virtue340b.com/virtue-340b-partners-with-hanys-marketplace/) [ ![340B Continuous Monitoring Contract Agency](https://virtue340b.com/wp-content/uploads/2026/02/hanys-marketplace-and-virtue340b-partnership-1024x526.jpg) ](https://virtue340b.com/virtue-340b-partners-with-hanys-marketplace/) ## Mar 11 2026 ## Why 340B Matters: A Response to PhRMA's Middleman Narrative This blog offers a clear, evidence-based response to that narrative by outlining what the 340B program actually does, who it serves, and why it remains indispensable for underserved patients and the safety-net providers who care for them. [Continue Reading →](https://virtue340b.com/why-340b-matters-phrma-middleman-narrative/) [ ![HRSA audit of 340B program integrity - compliance review process](https://virtue340b.com/wp-content/uploads/2025/09/pharmacy-compliant-pricing-1024x683.jpg) ](https://virtue340b.com/why-340b-matters-phrma-middleman-narrative/) ## Nov 24 2025 ## Planning for Change: The Intersection of IRA Maximum Fair Price and the 340B Rebate Policies The IRA's Maximum Fair Price and HRSA's 340B rebate pilot are set to reshape drug reimbursement in 2026. Learn how covered entities can prepare, prevent duplication, and stay compliant. [Continue Reading →](https://virtue340b.com/ira-maximum-fair-price-340b-rebate-policies/) [ ![HRSA audit of 340B program integrity - compliance review process](https://virtue340b.com/wp-content/uploads/2025/07/hrsa-audit-of-340b-program-integrity-1024x602.jpg) ](https://virtue340b.com/ira-maximum-fair-price-340b-rebate-policies/) ## Nov 3 2025 ## 340B Rebate Pilot: Why Purchase Data Isn't the Right Tool for Duplicate Discount Prevention As the 340B rebate pilot approaches its January 2026 launch, some argue that requiring purchase data will prevent duplicate discounts. But in practice, this approach introduces complexity, misaligned timing, and inconsistent reporting. Transactional claim data remains the most accurate and reliable method for identifying duplicate discounts, ensuring compliance, and maintaining program integrity - without undermining the pilot's core goals. [Continue Reading →](https://virtue340b.com/340b-rebate-pilot-why-purchase-data-isn-t-the-right-tool-for-duplicate-discount-prevention/) [ ![Pharmacy compliant pricing review for 340B drug program](https://virtue340b.com/wp-content/uploads/2025/10/340b-rebate-pilot.jpg) ](https://virtue340b.com/340b-rebate-pilot-why-purchase-data-isn-t-the-right-tool-for-duplicate-discount-prevention/) ## Oct 15 2025 ## Reflections from the 2025 MDRP Summit At the 2025 MDRP Summit, one theme was clear: collaboration between manufacturers, states, and covered entities is essential, but today's systems often inflate disputes and obscure the true value of 340B. Katy reflects on why better communication, accurate data, and good-faith engagement are critical to protecting patient care. [Continue Reading →](https://virtue340b.com/reflections-from-the-2025-mdrp-summit/) [ ![Virtue 340B - expert 340B consulting and audit services](https://virtue340b.com/wp-content/uploads/2025/10/virtue-340b.jpg) ](https://virtue340b.com/reflections-from-the-2025-mdrp-summit/) ## Oct 15 2025 ## The Benefits of 340B Consulting For Drug Pricing Program Proactive 340B audit readiness turns compliance into a strategic advantage, boosting data accuracy, oversight, and program performance. [Continue Reading →](https://virtue340b.com/benefits-of-340b-consulting-for-drug-pricing-program/) [ ![340b Drug Pricing Program](https://virtue340b.com/wp-content/uploads/2025/08/file.png) ](https://virtue340b.com/benefits-of-340b-consulting-for-drug-pricing-program/) ## Aug 5 2025 ## What to Look for in a Top 340B Consultant, Firm, or Auditor: Interview Questions to Ask Choosing the wrong 340B auditor can cost covered entities more than fees, it risks HRSA findings and compliance gaps. Learn how to vet the right, independent, knowledgeable partners who protect compliance and optimize program performance. [Continue Reading →](https://virtue340b.com/what-to-look-for-in-a-top-340b-consultant-firm-auditor/) [ ![file 17 - Virtue 340B consulting](https://virtue340b.com/wp-content/uploads/2025/07/file-17.png) ](https://virtue340b.com/what-to-look-for-in-a-top-340b-consultant-firm-auditor/) ## Jul 4 2025 - 1 - [2](https://virtue340b.com/page/2/?page_id=38&fl_builder) - [3](https://virtue340b.com/page/3/?page_id=38&fl_builder) - [Next »](https://virtue340b.com/page/2/?page_id=38&fl_builder)